Toleranzia

Chord Therapeutics

This clinical-stage biopharmaceutical company develops drugs for patients with rare neuroinflammatory diseases, including neuromyelitis optica spectrum disorder and generalized myasthenia gravis.

ArgenX

This company develops and commercialises antibody-based therapies to treat patients suffering from severe autoimmune diseases and cancer.

Nykode Therapeutics

This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.

Vor Bio

This biotechnology company develops therapies for patients living with serious autoantibody-driven autoimmune diseases, such as myasthenia gravis and Sjögren's disease.

Tolerance Bio, Inc.

This biopharmaceutical company develops thymus-based therapies to treat immune-mediated diseases including cancer, autoimmunity and transplant rejection for patients requiring restored immune tolerance.

Dualyx

This company develops immune-modulating therapies targeting regulatory T cells to treat patients with autoimmune diseases.

Abliva

This biopharmaceutical company develops novel medicines for patients suffering from rare and severe primary mitochondrial diseases.

Tolergyx

This company develops gastrointestinal immunotherapy capsules to treat food allergies in pediatric and adult patients.